Cepheid Receives Expanded FDA Clearance with CLIA Waiver for Xpert® Xpress MVP
/PRNewswire/ -- Cepheid announced today that it has received FDA Clearance with Clinical Laboratory Improvement Amendments (CLIA) waiver for Xpert® Xpress MVP....
Stay updated with breaking news from Xpert Xpress. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Cepheid announced today that it has received FDA Clearance with Clinical Laboratory Improvement Amendments (CLIA) waiver for Xpert® Xpress MVP....
Dublin, Jan. 16, 2024 (GLOBE NEWSWIRE) -- The
The global point of care diagnostics market revenue to reach USD 82.95 Billion by 2028....
Global infectious disease diagnostics market is growing at a CAGR of 6.8% from 2021 to 2028.Pune, India., Sept. 20, 2023 (GLOBE NEWSWIRE) -- Tuberculosis (TB) is the 13th most significant cause of mortality globally and the second leading infectious disease after COVID-19, according to the World Health Organization (WHO). According to the WHO, there were 1.5 million deaths due to TB in 2020 (including 214,000 HIV patients). WHO estimated that TB would affect 10 million individuals worldwide in 2
Operator: My name is Ashley, and I'll be your facilitator this morning. At this time, I would like to welcome everyone to the Danaher Corporation Second Quarter 2023 Earnings Conference Call.